Acute myocardial infarction
Conditions
Interventions
Rosuvastatin 10md/day
Sponsors
Iwate Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who diagnosed as AMI based on 4th universal definition and underwent percutaneous coronary intervention
Exclusion criteria
Exclusion criteria: (1) Cases who have a contraindication of rosuvastatin treatment (such as in patients receiving cyclosporine) or requires cautious administration (patients with hypothyroidism or patients planning to use fibrates other than fenofibrate). (2) Cases who have a side effects like muscle pain and poor tolerability to rosuvastatin oral administration. (3) Cases who have already used or have a plan to use other high cholesterol-improving medications (such as evolocumab or ezetimibe) during the observation period. (4) Cases of familial hypercholesterolemia. (5) Cases with chronic inflammatory diseases (autoimmune diseases) or ongoing cancer treatment. (6) Cases with impaired consciousness, general malaise, or severe mental disorders. (7) Other cases who are deemed inappropriate by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patients who fully achieved the guideline-recommended goal of lipid management, were defined as "achieved group". All the rest were defined as "unachieved group". Of them, incidence and relative factor of the unachieved group will be assessed in the present study. | — |
Countries
Japan
Contacts
Public ContactMasaru Ishida
Iwate Medical University Department of Internal Medicine, Division of Cardiology
Outcome results
None listed